Trastuzumab resistance: all roads lead to SRC

Muthuswamy, S. K. (April 2011) Trastuzumab resistance: all roads lead to SRC. Nature Medicine, 17 (4). pp. 416-8. ISSN 1078-8956

URL: http://www.ncbi.nlm.nih.gov/pubmed/21475230
DOI: 10.1038/nm0411-416

Abstract

A new study shows how SRC, a nonmembrane tyrosine kinase, is a common signaling node in trastuzumab resistance caused by different mechanisms in HER2-positive breast cancers (pages 461–469). A SRC inhibitor restored trastuzumab sensitivity in vitro and in mouse tumor models, suggesting a new way to tackle drug resistance in breast tumors.

Item Type: Paper
Subjects: diseases & disorders > cancer
diseases & disorders
therapies
diseases & disorders > cancer > cancer types > breast cancer
therapies > cancer drugs - see diseases-cancer-drugs and therapies
diseases & disorders > cancer > cancer types
CSHL Authors:
Communities: CSHL labs > Muthuswamy lab
Depositing User: Matt Covey
Date: April 2011
Date Deposited: 06 Feb 2013 19:24
Last Modified: 06 Feb 2013 19:24
Related URLs:
URI: http://repository.cshl.edu/id/eprint/27180

Actions (login required)

Administrator's edit/view item Administrator's edit/view item
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving